Carson Advisory Inc. Sells 2,700 Shares of GRAIL, Inc. $GRAL

Carson Advisory Inc. decreased its position in GRAIL, Inc. (NASDAQ:GRAL) by 23.5% during the 2nd quarter, according to the company in its most recent filing with the SEC. The fund owned 8,800 shares of the company’s stock after selling 2,700 shares during the quarter. Carson Advisory Inc.’s holdings in GRAIL were worth $452,000 at the end of the most recent reporting period.

Other large investors have also made changes to their positions in the company. Farther Finance Advisors LLC grew its holdings in shares of GRAIL by 768.1% in the 2nd quarter. Farther Finance Advisors LLC now owns 816 shares of the company’s stock worth $42,000 after purchasing an additional 722 shares during the last quarter. Roble Belko & Company Inc bought a new stake in shares of GRAIL in the 2nd quarter worth about $68,000. KBC Group NV grew its holdings in shares of GRAIL by 187.7% in the 1st quarter. KBC Group NV now owns 1,430 shares of the company’s stock worth $37,000 after purchasing an additional 933 shares during the last quarter. NewEdge Advisors LLC grew its holdings in shares of GRAIL by 390.3% in the 1st quarter. NewEdge Advisors LLC now owns 1,760 shares of the company’s stock worth $45,000 after purchasing an additional 1,401 shares during the last quarter. Finally, Signaturefd LLC grew its holdings in shares of GRAIL by 273.0% in the 1st quarter. Signaturefd LLC now owns 1,876 shares of the company’s stock worth $48,000 after purchasing an additional 1,373 shares during the last quarter.

Wall Street Analysts Forecast Growth

Several equities research analysts have recently weighed in on GRAL shares. Weiss Ratings reaffirmed a “sell (d-)” rating on shares of GRAIL in a report on Wednesday, October 8th. Canaccord Genuity Group increased their price objective on shares of GRAIL from $75.00 to $85.00 and gave the stock a “buy” rating in a report on Wednesday, October 22nd. Finally, UBS Group set a $75.00 price objective on shares of GRAIL in a report on Friday, October 3rd. One equities research analyst has rated the stock with a Buy rating, two have issued a Hold rating and one has issued a Sell rating to the stock. According to data from MarketBeat, GRAIL presently has an average rating of “Hold” and an average target price of $60.00.

GRAIL Stock Up 0.9%

Shares of NASDAQ:GRAL opened at $91.93 on Friday. The company’s 50-day moving average price is $56.96 and its two-hundred day moving average price is $44.71. The firm has a market cap of $3.31 billion, a P/E ratio of -7.01 and a beta of 4.11. GRAIL, Inc. has a 12 month low of $13.22 and a 12 month high of $103.00.

GRAIL (NASDAQ:GRAL) last announced its quarterly earnings data on Tuesday, August 12th. The company reported ($3.18) EPS for the quarter, missing analysts’ consensus estimates of ($3.14) by ($0.04). The firm had revenue of $35.54 million during the quarter, compared to analyst estimates of $37.57 million. GRAIL had a negative return on equity of 16.64% and a negative net margin of 329.86%. As a group, equities analysts predict that GRAIL, Inc. will post -15.15 earnings per share for the current fiscal year.

Insider Activity

In other news, CEO Robert P. Ragusa sold 7,239 shares of the firm’s stock in a transaction dated Wednesday, October 15th. The shares were sold at an average price of $68.88, for a total value of $498,622.32. Following the transaction, the chief executive officer owned 727,388 shares of the company’s stock, valued at approximately $50,102,485.44. This trade represents a 0.99% decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through this hyperlink. Also, President Joshua J. Ofman sold 81,385 shares of the firm’s stock in a transaction dated Monday, October 6th. The shares were sold at an average price of $62.50, for a total transaction of $5,086,562.50. Following the completion of the transaction, the president directly owned 396,797 shares in the company, valued at $24,799,812.50. This trade represents a 17.02% decrease in their position. The disclosure for this sale is available in the SEC filing. Insiders sold a total of 117,497 shares of company stock worth $7,515,436 in the last ninety days. Insiders own 1.85% of the company’s stock.

GRAIL Company Profile

GRAIL, Inc operates as a commercial-stage healthcare company, which engages in the development of a technology for early detection of cancer. It utilizes machine learning, software, and automation to detect and identify multiple deadly cancer types in earlier stages. The company was founded by Jeffrey T.